01:45 PM EST, 02/29/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our 12-month target price by $3 to $9, valuing GDRX shares at 23.7x our 2025 adjusted EPS estimate of $0.38 (raised today by $0.03), and at 30x our 2024 EPS estimate of $0.30 (upped by $0.01), versus a peer average of 26.6x. Q4 adjusted EPS of $0.08 versus $0.07 topped our EPS estimate and the consensus forecast of $0.07, amid 6.8% higher revenues, partly offset by 18% higher expenses (including a nearly three-fold rise in depreciation costs) that produced a GAAP net loss of $25.9 million versus $1.97 million. 2023 adjusted EPS of $0.28 versus $0.30 was comparable to our $0.27 EPS estimate and the $0.28 consensus view. We see adjusted revenues of $803 million in 2024 (versus $760.3 million posted in 2023), rising to $850 million in 2025. Though some mixed margin trends temper our view, we think decent top-line momentum and the benefits of a recent restructuring provide the dividend-less shares, which have risen over 17% year to date, with a catalyst.